Freshwater clam extract supplement‐induced acute cholestasis
Hiroaki Yokomori, Hitoshi Yamazaki, Masaya Oda – 30 October 2015
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Fernando Agüero, Alejandro Forner, Christian Manzardo, Andres Valdivieso, Marino Blanes, Rafael Barcena, Antoni Rafecas, Lluis Castells, Manuel Abradelo, Julian Torre‐Cisneros, Luisa Gonzalez‐Dieguez, Magdalena Salcedo, Trinidad Serrano, Miguel Jimenez‐Perez, Jose Ignacio Herrero, Mikel Gastaca, Victoria Aguilera, Juan Fabregat, Santos del Campo, Itxarone Bilbao, Carlos Jimenez Romero, Asuncion Moreno, Antoni Rimola, Jose M.
Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study
Jennifer C. Lai, Jennifer L. Dodge, Saunak Sen, Kenneth Covinsky, Sandy Feng – 30 October 2015 – Cirrhosis is characterized by sarcopenia and malnutrition, leading to progressive functional decline. We aimed to objectively measure functional decline in patients with cirrhosis awaiting liver transplantation and its association with waiting list mortality.
Nonalcoholic fatty liver disease activity score and mortality: Imperfect but not insignificant
Veeral Ajmera – 30 October 2015
Freshwater clam extract supplement‐induced acute cholestasis
Hiroaki Yokomori, Hitoshi Yamazaki, Masaya Oda – 30 October 2015
Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports
Einar S. Björnsson, Jay H. Hoofnagle – 30 October 2015 – An important element in assessing causality in drug‐induced liver injury is whether the implicated agent is known to cause hepatotoxicity. We classified drugs into categories based on the number of published reports of convincingly documented, clinically apparent, idiosyncratic liver injury. Drugs described in the website LiverTox (http://livertox.nih.gov) were classified into five categories based on the number of published cases (category A, ≥50; category B, 12‐49; category C, 4‐11; category D, 1‐3; category E, none).
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection
Maria Antonella Burza, Benedetta Maria Motta, Rosellina Margherita Mancina, Piero Pingitore, Carlo Pirazzi, Saverio Massimo Lepore, Rocco Spagnuolo, Patrizia Doldo, Cristina Russo, Veronica Lazzaro, Janett Fischer, Thomas Berg, Alessio Aghemo, Cristina Cheroni, Raffaele De Francesco, Silvia Fargion, Massimo Colombo, Christian Datz, Felix Stickel, Luca Valenti, Stefano Romeo – 30 October 2015 – Chronic hepatitis C virus (HCV) infection may progress to cirrhosis and hepatocellular carcinoma (HCC).
Reply
Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stal, Stergios Kechagias, Rolf Hultcrantz – 30 October 2015
Clinical characteristics and outcomes of pyogenic vertebral osteomyelitis in patients with cirrhosis
Seong Yeon Park, Ki‐Ho Park, Oh‐Hyun Cho, Yu‐Mi Lee, Sang‐Ho Choi, Mi Suk Lee – 30 October 2015
Hemophilia B acquired through liver transplantation
Denise Menezes Brunetta, Fabiana Aguiar Carneiro‐Silva, João Batista Marinho Vasconcelos, Rosângela de Albuquerque Ribeiro, Denissa Ferreira Gomes Mesquita, Gustavo Rego Coelho, Fernando Barroso‐Duarte, José Huygens Parente Garcia – 29 October 2015